SUN Pharmaceutical Industries Limited β Erlotinib Exporter Profile
Indian Pharmaceutical Exporter Β· #8 for Erlotinib Β· $54.2K export value Β· DGFT Verified
SUN Pharmaceutical Industries Limited is the #8 Indian exporter of Erlotinib with $54.2K in export value and 12 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.0% market share in Erlotinib exports across 3 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited β Erlotinib Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Erlotinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $23.6K | 2 | 43.5% |
| UNITED STATES | $20.1K | 8 | 37.1% |
| THAILAND | $10.5K | 2 | 19.4% |
SUN Pharmaceutical Industries Limited exports Erlotinib to 3 countries. The largest destination is PERU accounting for 43.5% of SUN Pharmaceutical Industries Limited's Erlotinib shipments, followed by (37.1%) and (19.4%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.